fluorodeoxyglucose f18 has been researched along with dihydrotestosterone in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (57.14) | 29.6817 |
2010's | 3 (42.86) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Engelbach, JA; Jones, LA; Kim, J; Mercer, NM; Oyama, N; Sharp, TL; Welch, MJ | 1 |
Akhurst, TA; Beattie, B; Bornmann, W; Dyke, J; Erdi, Y; Finn, RD; Gunther, I; Humm, JL; Larson, SM; McCarthy, T; Morris, M; Pentlow, K; Scher, H; Squire, O; Welch, M | 1 |
Bansal, A; DeGrado, TR; Hara, T | 1 |
Emonds, KM; Mortelmans, L; Mottaghy, FM; Swinnen, JV | 1 |
Brower, V | 1 |
Autran-Blanc, E; Fox, JJ; Gavane, S; Gönen, M; Humm, JL; Larson, SM; Morris, MJ; Nehmeh, S; Scher, HI; Schöder, H; Van Nuffel, A | 1 |
Fox, JJ; Goldman, DA; Gonen, M; Hricak, H; Kuk, D; Larson, SM; Morris, MJ; Scher, HI; Vargas, HA; Wassberg, C; Wibmer, A | 1 |
1 review(s) available for fluorodeoxyglucose f18 and dihydrotestosterone
Article | Year |
---|---|
Molecular imaging of prostate cancer.
Topics: Animals; Antigens, Neoplasm; Bombesin; Cell Line, Tumor; Choline; Dideoxynucleosides; Dihydrotestosterone; Fluorodeoxyglucose F18; GPI-Linked Proteins; Humans; Male; Membrane Glycoproteins; Molecular Diagnostic Techniques; Neoplasm Proteins; Positron-Emission Tomography; Prostate; Prostatic Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon | 2009 |
1 trial(s) available for fluorodeoxyglucose f18 and dihydrotestosterone
Article | Year |
---|---|
Tumor localization of 16beta-18F-fluoro-5alpha-dihydrotestosterone versus 18F-FDG in patients with progressive, metastatic prostate cancer.
Topics: Aged; Bone Neoplasms; Dihydrotestosterone; Fluorodeoxyglucose F18; Humans; Male; Metabolic Clearance Rate; Middle Aged; Prostatic Neoplasms; Radiopharmaceuticals; Receptors, Androgen; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution; Tomography, Emission-Computed; Whole-Body Counting | 2004 |
5 other study(ies) available for fluorodeoxyglucose f18 and dihydrotestosterone
Article | Year |
---|---|
MicroPET assessment of androgenic control of glucose and acetate uptake in the rat prostate and a prostate cancer tumor model.
Topics: Acetates; Androgen Antagonists; Androgens; Animals; Carbon; Diethylstilbestrol; Dihydrotestosterone; Disease Models, Animal; Fluorodeoxyglucose F18; Humans; Injections, Intraperitoneal; Injections, Subcutaneous; Male; Mice; Mice, Nude; Neoplasm Transplantation; Organ Specificity; Prostate; Prostatic Neoplasms; Radiopharmaceuticals; Rats; Tissue Distribution; Tomography, Emission-Computed | 2002 |
Effect of hypoxia on the uptake of [methyl-3H]choline, [1-14C] acetate and [18F]FDG in cultured prostate cancer cells.
Topics: Acetates; Adenosine Triphosphate; Carbon Radioisotopes; Cell Count; Cell Hypoxia; Cell Line, Tumor; Cell Survival; Choline; Dihydrotestosterone; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Tritium | 2006 |
Beyond FDG: Many Molecular Imaging Agents Are in Development.
Topics: Biomarkers, Tumor; Breast Neoplasms; Dihydrotestosterone; Drug Design; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Male; Neoplasms; Nuclear Medicine; Positron-Emission Tomography; Prostatic Neoplasms; Radiology; Radiopharmaceuticals; Receptor, ErbB-2; Receptors, Androgen; Sensitivity and Specificity; Tomography, X-Ray Computed | 2011 |
Practical approach for comparative analysis of multilesion molecular imaging using a semiautomated program for PET/CT.
Topics: Automation; Biomarkers, Tumor; Dihydrotestosterone; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Molecular Imaging; Multimodal Imaging; Orchiectomy; Positron-Emission Tomography; Prostatic Neoplasms; Reference Standards; Retrospective Studies; Tomography, X-Ray Computed | 2011 |
Bone metastases in castration-resistant prostate cancer: associations between morphologic CT patterns, glycolytic activity, and androgen receptor expression on PET and overall survival.
Topics: Aged; Aged, 80 and over; Bone Neoplasms; Cross-Sectional Studies; Diatrizoate; Diatrizoate Meglumine; Dihydrotestosterone; Fluorodeoxyglucose F18; Glycolysis; Humans; Male; Multimodal Imaging; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Receptors, Androgen; Retrospective Studies; Survival Rate; Tomography, X-Ray Computed | 2014 |